Andrew Conway Morris
-
- Nosocomial Infections in ICU 28
- Intensive Care Unit Cognitive Disorders 8
-
- Antibiotic Use and Resistance 9
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 8
- Epidemiology top 2%
- Pneumonia and Respiratory Infections 24
- Sepsis Diagnosis and Treatment 15
- Respiratory viral infections research 10
- Infectious Diseases top 2%
-
- Immune Response and Inflammation 17
- Co-authors
- A. John SimpsonIan F. LaurensonNaomi J. GadsbyKate TempletonAdam T. HillTimothy WalshM. McHughClark D Russell
- Cited by
- Critical Care and Intensive Care MedicineApplied Microbiology and BiotechnologyMolecular Medicine
- Journals
- Proceedings of the National Academy of Sciences (1 paper)The Lancet (3 papers)Nature Communications (1 paper)
- Partner nations
- United KingdomUnited StatesPortugal
In The Last Decade
Andrew Conway Morris
95 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Critical Care and Intensive Care Medicine 701
- Applied Microbiology and Biotechnology 159
- Molecular Medicine 222
- Epidemiology 1.1k
- Infectious Diseases 578
Countries citing papers authored by Andrew Conway Morris
This map shows the geographic impact of Andrew Conway Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Conway Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Conway Morris more than expected).
Fields of papers citing papers by Andrew Conway Morris
This network shows the impact of papers produced by Andrew Conway Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Conway Morris. The network helps show where Andrew Conway Morris may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew Conway Morris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 15 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 5 | |
| 8 | How to use biomarkers of infection or sepsis at the bedside: guide to cliniciansbreakdown → | 2023 | 134 |
| 9 | 2023 | 0 | |
| 10 | 2023 | 7 | |
| 11 | 2021 | 6 | |
| 12 | 2021 | 5 | |
| 13 | 2020 | 30 | |
| 14 | 2016 | 3 | |
| 15 | 2016 | 6 | |
| 16 | 16S PAN-BACTERIAL PCR CAN ACCURATELY IDENTIFY PATIENTS WITH VENTILATOR ASSOCIATED PNEUMONIA | 2014 | 2 |
| 17 | 2013 | 17 | |
| 18 | 2013 | 13 | |
| 19 | 2009 | 313 | |
| 20 | 2009 | 88 |
About Andrew Conway Morris
Andrew Conway Morris is a scholar working on Critical Care and Intensive Care Medicine, Applied Microbiology and Biotechnology and Molecular Medicine, having authored 104 papers that have together received 3.1k indexed citations. Recurring topics across this work include Nosocomial Infections in ICU (28 papers), Pneumonia and Respiratory Infections (24 papers), Immune Response and Inflammation (17 papers), Sepsis Diagnosis and Treatment (15 papers), Respiratory viral infections research (10 papers), Antibiotic Use and Resistance (9 papers), Intensive Care Unit Cognitive Disorders (8 papers) and Antibiotic Resistance in Bacteria (8 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (701 citations), Applied Microbiology and Biotechnology (159 citations) and Molecular Medicine (222 citations). Andrew Conway Morris has collaborated with scholars based in United Kingdom, United States and Portugal. Frequent co-authors include A. John Simpson, Ian F. Laurenson, Naomi J. Gadsby, Kate Templeton, Adam T. Hill, Timothy Walsh, M. McHugh, Clark D Russell, Kevin Dhaliwal and Thomas S. Wilkinson. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.